PharmaSGP Holding SE

  • WKN: A2P4LJ
  • ISIN: DE000A2P4LJ5
  • Land: Deutschland

Nachricht vom 27.08.2021 | 15:08

PharmaSGP Holding SE: Release according to Article 111c of the AktG [the German Stock Corporation Act] with the objective of Europe-wide distribution

PharmaSGP Holding SE / Release of an announcement according to Article 111c of the AktG [the German Stock Corporation Act]
27.08.2021 / 15:08
Dissemination of a Related Party Transactions announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Disclosure pursuant to Section 111c of the German Stock Corporation Act

PharmaSGP Holding SE: Increase and repayment of loan financing provided by majority shareholder

Graefelfing, August 27, 2021. In order to finance value added tax payments in connection with the closing of the acquisition of a product portfolio of OTC brands from the GlaxoSmithKline Group announced in June 2021, PharmaSGP Holding SE has taken up a further shareholder loan from FUTRUE GmbH with date of August 26, 2021.

FUTRUE GmbH holds a majority participation in PharmaSGP Holding SE and is in turn solely owned by the chairman of the supervisory board of PharmaSGP Holding SE; therefore, the financing is a transaction of the Company with a related party which is subject to disclosure pursuant to Section 111c of the German Stock Corporation Act.

The newly raised shareholder loan is unsecured and has a volume of EUR 12 million. The loan interest rate will be determined based on a benchmark analysis for the applicable market interest rate, which has yet to be carried out. The loan has a minimum term until December 31, 2021 and is then automatically extended once or more times, in each case by a further three-month period, until December 31, 2022 at the latest, unless it is terminated by the lender. However, the Company will repay the loan before the end of the year once the value added tax payments that the loan was taken out to finance are refunded to the Company by the tax authorities.

FUTRUE GmbH had already granted the Company a shareholder loan in the amount of EUR 85 million in June 2021 to finance the acquisition of the afore-mentioned product portfolio. The Company will refinance this shareholder loan through bank financing and repay it in full in the week of August 30, 2021.



27.08.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

IPO im Fokus

MIT SICHERHEIT AUFS PARKETT. UNSER BÖRSENGANG ZUR WACHSTUMSBESCHLEUNIGUNG

ISIN: DE000A3CM708
Grundkapital (vor IPO): 3.120.000 EUR
Angebotene Aktien: bis zu 690.000 Aktien
Zeichnungsfrist: 11.10.2021 bis voraus. 25.10.2021
Bookbuildingspanne: 3,30 bis 3,60 Euro
Börse: Börse Düsseldorf

Rechtlich maßgeblicher Wertpapierprospekt auf sdm-se.de

Event im Fokus

Termine 2021

10. Juni 2021:Fachkonferenz Immobilien

14./15. Juli 2021: Fachkonferenzen Beteiligungsgesellschaften & Consumer/Leisure

13./14. Oktober 2021: Fachkonferenzen Finanzdienstleistungen/Technologie

10./11. November 2021: Fachkonferenzen Software/IT & Branchenmix

„Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen entscheidet sich ca. 5 Wochen vor dem Termin, in welcher Form die Konferenzen stattfinden.“

IIF – International Investment Forum

Wann: 14. Oktober 2021, 9:45 - 18:00 Uhr
Wo: Online Live-Event via ZOOM
Wer: börsennotierte Unternehmen aus den Small- und Midcap-Segmenten aller Welt
Branchen: Technologie, Rohstoffe, Sicherheit, Medizin, Logistik und Raumfahrt
Für: Alle Investoren & Presse
Weitere Informationen: www.ii-forum.com

News im Fokus

Delivery Hero verstärkt seine Präsenz in Zentralamerika und der Karibik durch die Übernahme der Restaurant- und Lebensmittellieferdienste von hugo

14. Oktober 2021, 08:00

Aktuelle Research-Studie

2G Energy AG

Original-Research: 2G Energy AG (von First Berlin Equity Research GmbH): Hinzufügen

15. Oktober 2021